Principal Financial Group Inc. grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 2.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 226,491 shares of the company’s stock after purchasing an additional 5,408 shares during the quarter. Principal Financial Group Inc. owned about 0.50% of Azenta worth $7,846,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Farther Finance Advisors LLC grew its position in Azenta by 788.1% in the 1st quarter. Farther Finance Advisors LLC now owns 968 shares of the company’s stock worth $33,000 after purchasing an additional 859 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Azenta in the 4th quarter worth $40,000. Covestor Ltd grew its position in Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company’s stock worth $102,000 after purchasing an additional 799 shares during the last quarter. Quarry LP acquired a new stake in Azenta in the 4th quarter worth $110,000. Finally, Sterling Capital Management LLC boosted its position in shares of Azenta by 39.8% during the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company’s stock valued at $143,000 after acquiring an additional 813 shares in the last quarter. Institutional investors own 99.08% of the company’s stock.
Azenta Stock Down 1.0%
Shares of AZTA stock opened at $31.91 on Wednesday. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $63.58. The company has a market capitalization of $1.46 billion, a P/E ratio of -22.96 and a beta of 1.64. The firm has a 50-day moving average price of $29.44 and a 200 day moving average price of $36.82.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Evercore ISI lifted their target price on shares of Azenta from $29.00 to $35.00 and gave the company an “in-line” rating in a research report on Tuesday, July 8th. Needham & Company LLC decreased their target price on shares of Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a research report on Wednesday, May 7th.
Check Out Our Latest Stock Report on Azenta
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- Quiet Period Expirations Explained
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- 3 Warren Buffett Stocks to Buy Now
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- Stock Analyst Ratings and Canadian Analyst Ratings
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.